2025 Vaistinių preparatų vertinimai
Paraiškos numeris | Vaistinio preparato pavadinimas | Veiklioji medžiaga | TLK-AM-10 | Rekomendacijos pateikimo data |
STV-201 | Spinraza | Nusinerseno natrio druska | G12.0; G12.1 | |
| STV-184 | Rinvoq | Upadacitinibas | M46.8 | 2025-02-17 |
| STV-175 | Opdivo | Nivolumabas | C15 | 2025-02-17 |
| STV-186 | Opdivo | Nivolumabas | C15-C16 | 2025-03-14 |
| STV-168 | Imbruvica | Ibrutinibas | C91.1 | 2025-03-14 |
| STV-158 | Tibsovo | Ivosidenibas | C92.0 | 2025-03-17 |
| STV-173 | Lynparza | Olaparibas | C56; C57; C48 | 2025-03-25 |
| STV-180 | Imfinzi | Durvalumabas | C22.1; C23; C24 | 2025-03-26 |
| STV-195 | Libtayo | Cemiplimabas | C34 | 2025-03-27 |
| STV-194 | Libtayo | Cemiplimabas | C34 | 2025-04-30 |
| STV-188 | Trodelvy | Sacituzumabas govitekanas | C50 | 2025-04-30 |
| STV-210 | Tevimbra | Tislelizumabas | C34 | 2025-04-30 |
| STV-211 | Tevimbra | Tislelizumabas | C34 | 2025-04-30 |
| STV-218 | Skyrizi | Risankizumabas | K51 | 2025-04-30 |
| STV-212 | Tevimbra | Tislelizumabas | C34 | 2025-05-19 |
| STV-187 | Inrebic | Fedratinibas | D45; D47.1; D47.3 | 2025-05-21 |
| STV-220 | Braftovi+Mektovi | Enkorafenibas+ binimetinibas | C43 | 2025-05-26 |
| STV-169A | Orladeyo | Berotralstatas | D84.1 | 2025-05-30 |
| STV-191 | Epidyolex (DS) | Kanabidiolis | G40.81 | 2025-06-03 |
| STV-192 | Epidyolex (LGS) | Kanabidiolis | G40.41 | 2025-06-03 |
| STV-193 | Epidyolex (TSC) | Kanabidiolis | Q85.1 | 2025-06-03 |
| STV-189 | Keytruda | Pembrolizumabas | C64 | 2025-06-17 |
| STV-231 | Taltz | Iksekizumabas | M45 | 2025-06-19 |
| STV-196 | Libtayo | Cemiplimabas | C53 | 2025-08-08 |
| STV-232 | Taltz | Iksekizumabas | M07 | 2025-08-08 |
| STV-202 | Keytruda | Pembrolizumabas | C64 | 2025-08-08 |
| STV-207 | Forxiga | Dapagliflozinas | N18 | 2025-08-08 |
| STV-213 | Lonsurf | Trifluridinas ir Tipiracilas | C18-20 | 2025-08-12 |
| STV-198 | Tecvayli | Teklistamabas | C90.0 | 2025-08-12 |
| STV-203 | Keytruda | Pembrolizumabas | C34 | 2025-08-13 |
| STV-225 | Elahere | Mirvetuksimabo soravtansinas | C48, C56, C57 | 2025-09-30 |
| STV-208 | Columvi | Glofitamabas | C83.3, C85.2 | 2025-09-30 |
| STV-205 | Fruzaqla | Frukvintinibas | C18-C20 | 2025-09-30 |
| STV-199 | Camzyos | Mavakamtenas | I42.1 | 2025-09-30 |
| STV-217 | Opdivo | Nivolumabas | C15 | 2025-09-30 |
| STV-227 | Kisqali | Ribociklibas | C50 | 2025-09-30 |
| STV-238 | Leqvio | Inklisiranas | E78, I20.0, I20.8, I21, I25.2, Z95.5, Z95.1. | 2025-09-30 |
| STV-209 | Tevimbra | Tislelizumabas | C15 | 2025-09-30 |
| STV-240 | Rinvoq | Upadacitinibas | M31.5, M31.6 | 2025-10-27 |
| STV-249 | Nalgesin forte | Naprokseno natrio druska | C00–D48, G00–G99, M00–M99, S00–T31 | 2025-10-27 |
| STV-223 | Vyndaqel | Tafamidis | E85.8 su I43.1 | 2025-10-28 |
| STV-219 | Braftovi | Enkorafenibas | C18-C21 | 2025-10-28 |
| STV-221 | Tevimbra | Tislelizumabas | C15 | 2025-10-28 |
| STV-239 | Rubraca | Rukaparibas | C48, C56, C57 | 2025-11-03 |
| STV-241 | Repatha | Evolokumabas | E78, I20.0, I20.8, I21, I25.2, I63, I69.3, Z95.5, Z95.1 | 2025-11-25 |
| STV-243 | Repatha | Evolokumabas | E78.0 | 2025-11-25 |
| STV-215 | Scemblix | Asciminibas | C92.1 | 2025-11-25 |
| STV-235 | Imfinzi | Durvalumabas | C34 | 2025-11-25 |
| STV-222 | Tevimbra | Tislelizumabas | C16 | 2025-12-02 |
| STV-236 | Beyonttra | Akoramidis | E85.8 ir I43.1 | 2025-12-18 |
| STV-214A | Jaypirca | Pirtobrutinibas | C83.1 | 2025-12-18 |
| STV-229 | Keytruda | Pembrolizumabas | C53 | 2025-12-18 |
| STV-228 | Ryeqo | Relugoliksas/Estradiolis/Noretisterono acetatas | N80 | 2025-12-18 |
| STV-216 | Alcensa | Alektinibas | C33, C34 | 2025-12-22 |
| STV-247 | Cejemly | Sugemalimabas | C34 | 2025-12-22 |
| STV-237 | Bimzelx | Bimekizumabas | L40 | 2025-12-22 |
| STV-224 | Rybrevant | Amivantamabas | C34 | 2025-12-22 |
| STV-244 | Imfinzi | Durvalumabas | C34 | 2025-12-22 |
| STV-226 | Tagrisso | Osimertinibas | C34 | 2025-12-22 |
| STV-245 | Imfinzi | Durvalumabas | C54 | 2025-12-22 |
| STV-246 | Rybrevant+Lazcluze | Amivantamabas+lazertinibas | C34 | 2025-12-29 |
Atnaujinimo data: 2026-02-25